TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Skandinavisk BioTech AB
Closing information (x1000 NOK)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
5,830
|
5,597 | |
| Financial expenses |
3
|
1 | |
| Earnings before taxes |
801
|
889 | |
| EBITDA |
700
|
879 | |
| Total assets |
9,376
|
8,070 | |
| Current assets |
6,979
|
6,030 | |
| Current liabilities |
979
|
832 | |
| Equity capital |
7,744
|
6,711 | |
| - share capital |
98
|
92 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
82.6%
|
83.2% | |
| Turnover per employee |
5,830
|
5,597 | |
| Profit as a percentage of turnover |
13.7%
|
15.9% | |
| Return on assets (ROA) |
8.6%
|
11.0% | |
| Current ratio |
712.9%
|
724.8% | |
| Return on equity (ROE) |
10.3%
|
13.2% | |
| Change turnover |
-104
|
1,903 | |
| Change turnover % |
-2%
|
-2%
|
52% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.